1 final scientific program1 (1) · new nice guidelines : a realistic compromise? - b williams...

Scientific Program

Exercise-Induced Cardiac Troponin I - PP Mohanan Polypill for Cardiovascular Disease Prevention in an Underserved Population - K VenugopalYear in Hypertension - B Williams

Curtain Raiser - What was new this year?09.30-10.45 am

Atrial Fibrillation10.45-12.15pm

12+6min12+6min

18 + 4min

12+6min18+4min12+6min12+6min

Long term complications of A fib - U PandurangiPost operative A Fib : Is it benign? - B GershWhich NOAC for which patient? - A BhagwatEmerging indications for RF ablation - A VoraDiscussion

Rethinking current treatment strategies of BP Management 12.00-1.15pm

Combination therapy - A trend set in India2.15-3.45pm

12+4min12+4min12+4min

18min

Home BP monitoring - T NairRound the clock control of BP - NV DeshpandeIs sodium restriction effective for lowering blood pressure? - U JadhavNew NICE guidelines : a realistic compromise? - B WilliamsDiscussion

1.30-2.15pm Lunch

18+4min

18+4min

18+4min

5min

How wider use of combinations will improve control of the main cardiovascular risk factors - R Gupta Therapeutic Adherence- mainstay in reaching BP goal - JJ DalalTriple drug antihypertensive SPCs: the logical choice for Indian scenario - S RayDiscussion

DAY I 8TH NOV,FRIDAY HALL I

Panchayat - Off patent Ticagrelor, a turning point in management of ACS?

5.30-6.45pm

12min12min12min12min30min

Plaque to thrombosis to ACS - R MathewP2Y12 inhibitors : How they are different - G KoshyDAPT up-to-date - MS HiremathACSnomics - HM MardikarDiscussion

Panchayat - Lipid Management 6.45-8.00pm

15min15min15min15min

IntroductionIs it right time to screen for high LPA? - S RayHypertriglycedemia : How to diagnose & how to treat? - S KaleHigh dose statins in the era of PCSK9 inhibitors – JJ DalalDiscussion

Cardiology, Kidney & Diabetes (CKD)3.45-5.00pm

22+8min

22+8min15min

Introduction The benefits of GLP1RAs and SGLT2i on CV outcomes: how similar? how different?- S Del PratoIs DAPA HF a game changer? - J McMurrayPanel Discussion

5.00-5.30pm

DAY I 8TH NOV,FRIDAY HALL II

Break

Curtain Raiser - What was new this year?09.30-10.45 am

10+5min

10+5min

10+5min

Introduction - S KaleLack of Glycemic Legacy Effects in the Veterans Affairs Diabetes Trial - A NigamCalorie restriction and cardiometabolic risk (CALERIE) - U.AyyagariAge at diagnosis & CV disease - S Kale Discussion

Personalised medicine - for CV Disease in young diabetics 10.45-12.15pm

15+3min15+3min

20min

Calcium score & CT Angio - N DesaiAspirin, statin or both? - SS IyengarOral combination therapy in early stage - P GaedePanel DiscussionQ & A

Reducing hypoglycaemia in patients treated with insulin12.15-1.30pm


Impact of hypoglycaemia - M FisherImpact of impaired renal function - S.ShahImpact of addition of SGLT2 inhibitors - S Del PratoDiscussion

Drugs for the Heart in Diabetes Session I 2.15-3.45pm


18+4min

Will paradigm shift away from SU's? -A.K.DasAlpha Glucosidase Inhibitors & Heart- S ShaikhHave DPP4 inhibitors come to a dead end? - M ChadhaT2DM Management Beyond HbA1c: The Vasculo-Metabolic Axis & Place of SGLT2-inhibitors - P Sanzgiri

Drugs for the Heart in Diabetes Session II3.45-5.00pm

18+4min18+4min

18+4min

The right glucose-lowering drugs for the right patient - A.K.DasGlycemic Control and CV Outcome: Twin Aspects-DPP4i + SGLT2i FDC- M JohnRevisiting STENO & CV risk reduction with newer glucose lowering drugs - P GaedeDiscussion

1.30-2.15pm Lunch

5.00-5.30pm Break

EACD Classroom - Session IPersonalised medication in type 2 DM

5.30-6.45pm

25min25min

The Era of Precision medicine in diabetes - S Del PratoPersonalised treatment of HF - J McMurrayDiscussion

2.15-3.45pm ECG Masterclass

B Gersh, U Pandurangi & A Vora

5.30-6.45pm Discuss with the Expert on the spot I

When should we stop Aspirin in elderly?Dr NV Deshpande with Dr Jamshed DalalARNI in uncontrolled HTDr A Bhagwat with Prof B WilliamsPCSK9 inhibitorsDr PP Mohanan with Dr SS Iyengar

5.00-5.30pm Break

3.45-5.0pm

25min

25min

25min

6.45-8.00pm Discuss with the Expert on the spot IICardiovascular consequences of sleep apneaDr NV Deshpande with Prof Bernard GershSelecting SGLT2 inhibitors based on patient profileDr A Nigam with Prof Stefano Del PratoARNI in HFDr A Dhall with Prof J McMurray

25min

25min

25min

ECG Quiz

ECG 1 -M.S. VISNUDASECG 2 - Akshay bafnaIECG 3 -vikas singhECG 4 - Nilesh BanthiaECG 5 - S N PandaECG 6 - Seba Mathew

DAY I 8TH NOV,FRIDAY ECO-Hall

EACD Classroom - Session IINew Insights

6.45-8.00pm

20min20min

Do we need lower BP targets for diabetics? - B WilliamsCirculating liver enzymes & Diabetes - E FerranniniDiscussion

Gaps in Knowledge - AMI

Lytic therapy when PCI centre in nearby - R MathewBeta blockers in post AMI management - A BanerjeeCardiogenic Shock - A DhallAICD indications - do we need to revisit in era of ARNI & SGLT2i ? - U PandurangiDiscussion

9.00-10.15am

10.15-10.45am


Remogliflozin - SGLT2 inhibitor for common man - S Kale, M John

Guest Lectures

Insulin resistance - E FerranniniUnderstanding nuances in management of HT : ProtectingHearts and Minds - B WilliamsNew guidelines in DM - S Del Prato

10.45-12.00noon

20+5min20+5min

20+5min

Guest Lectures

Treating patients with HFpEF : WHat progress are we making? - J McMurrayDiabetes prevention and early treatment - S Del PratoCardiovascular consequences of sleep apnea and what can we do about it ? - B Gersh

12.00-1.15pm

20+5min

20+5min20+5min

Opportunities to optimise management of HF

Walk-in patient with stable HF patient - B PintoPatient of decompensated HF at discharge - J McMurrayPanel Discussion & audience interaction

3.15-4.30pm

15min20min30min

DAY II 9TH NOV,SATURDAY HALL I

Adda Break

Lunch1.15-2.00pm

Panchayat2.00-3.15pm

25min12min30min

SGLT2 inhibitors, CREDENCE & Peep into future - E FerranniniCREDENCE - A Nephrologists view - A KirpalaniDiscussion

Award Ceremony Legends TalkLegend of Diabetes Award

Statins & Ezitimibe combination is back!Discussant - JJ Dalal, NV Deshpande, U Jadhav

Breakfast Session - Mini-Debates

Treating Obesity & Diabetes - Start with metformin & SGLT2 i combination Pro - S KotaCon - S.ShahDiscussionTreating BP Control - Drug MattersPro - K VenugopalCon - T NairDiscussion

8.00-9.00am

12min12min6min

12min12min6min

Gaps in Knowledge - CardioDiabetes

Efficacy and safety of SGLT2 inhibitors in elderly - M FisherNocturnal hypertension in diabetes - JJ DalalWho should be the Leader? Diabetologist, Nephrologist or Cardiologist? - A KirpalaniAspirin for primary prevention in Diabetes - JS BhuvaneswaranDiscussion

9.00-10.15am

10.15-10.45am Break


12+6min15min

DAY II 9TH NOV,SATURDAY HALL II

Panchayat - Blood Pressure in a 100-Year Perspective5.15-6.30pm

6.30-7.00pm

Champagne Reception7.00pmDinner7.30pm

20min20min20min

15min

Understanding Hypertension - E FerranniniHow did we arrive at proper targets? - T NairRedefining diuretics use in hypertension: why select a thiazide-like diuretic? - B WilliamsDiscussion

4.30-5.15pm Adda Break

Lunch1.15-2.00pm

Debate & Discuss

Should HbA1c still be the main target for diabetes treatment?Pro - U AyyagariCon - P GaedeRebuttal IRebuttal IIDiscussionControversies about HbA1c targets - GananpathiDiscussion

10.45-12.00noon

15min15min3min3min

10min18min10min

Targets.....Targets.....Targets.....

Blood pressure target to <120 /<70 mmHg associates with poor outcomePro - A BhagwatCon - PP MohananRebuttal IRebuttal IIDiscussionHT Management - Identifying right patient & right target - B WilliamsDiscussion

12.00-1.15pm

15min15min3min3min

10min18min

10min

Insulin Symposium

Moving from Orals to Injectables....Why,When & How?- A Nigam"Choosing basal insulin over SGLT2 inhibitors - P GaedeBE-SMART: Basal Early Strategies to Maximize A1C Reductionwith Oral Therapy - V NegalurDissecting head to head data of newer generation basal insulin - AG UnnikrishnanDiscussion

2.00-3.15pm

15min

15min15min

15min

15min

The real science behind what we eat!

Gut response to food - E FerranniniIntermittent fasting - R AdlyneScientific evidence of diet in cardio-metabolic health - Rajiv GuptaDiscussion

3.15-4.30pm

18min15min18min

20min

DAY II 9TH NOV,SATURDAY HALL III

8 slides + 10mins8 slides + 10mins8 slides + 10mins8 slides + 10mins

Can diet fads increase CV risk? - NV DeshpandeReducing obesity with antidiabetics - S ShaikhPostprandial hyperglycemia - A NigamPioglitazone in clinical practice - M John

4.30-5.15pm

Open Mike symposium 5.15-6.30pm

Break

Award Ceremony Legends TalkLegend of Diabetes Award

6.30-7.00pm

Champagne Reception7.00pm

Dinner7.30pm

15min


Doctor and patient perspectiveDiabetes educator perspectiveRevenue model for the doctor Revenue for the industry (Moderators to discuss. No speakers)

Digital apps for diabetes treatment and prevention: opportunities and challenges

9.00-10.15am

Dealing with atypical diabetes in India- GanapathiShould we start insulin early? - R AdlyneShould everybody receive Aspirin & Statin ? - A BanerjeeAre DPP4 inhibitors still second line therapy after Metformin? - M FisherDiscussion

Contentious issues in management of Young Diabetics (<40yrs)

10.45-12.00noon

10.15-10.45am Break

12+6min


"Prevention of Heart Failure in Diabetes:Role of Antihypertensive Therapy - A Pareek"IV decongestion therapy in-hospital - K SharmaMineralocorticoid receptor antagonists - GL SharmaHow to prevent hyponatremia? - S Banerjee

Contentious issues - Management of HF2.00-3.15pm


The Chocolates - Shilpa JoshiThe red wine - S KaleAlcohol - S RayDiscussion

So called Vices - Advising patients based on science3.15-4.30pm

Pregnancy & Diabetes- Moderators-S.Kale , S.ShaikhCase Based Discussions

EACD Classroom- Session III9.00-10.00am

Thyroid Disorders- Moderators-S.Shah, M.JohnCase Based Discussions

EACD Classroom- Session IV10.00-10.45am

Managing type 1 DM-Important aspects- Moderators-A Nigam, M.JohnCase Based Discussions

EACD Classroom- Session V4.30-5.15pm

DAY II 9TH NOV,SATURDAY EACD Classroom

1.15-2.00pm

12.00-1.15pm

Lunch

Contentious issues in management of Diabetes

12+6min12+6min

12+6min12+6min

Anaemia Ferritin and Iron therapy in diabetes- V.Negalur"Fatty Liver: Diagnostic Tests and Therapeutic Options -A Nigam"D2d study- Vit D and type 2 diabetes- Sunil KotaRange of blood glucose in a day A new target?in type 2 dm - S Shaikh

Breakfast session - Living Longer Living Better

The Secret to Good Health : 10,000 Steps, fitbit & the science - T NairArtificial intelligence, Retina & CVD - HM MardikarAssessment of myocardial viability: In whom, how and why? - A Bhagwat

8.15-9.15am

15+4min

15+4min15+4min

EASD Highlights

Comparing metformin vs metformin pus Vildagliptin - the VERIFY trial - P GaedeComparing degludec vs U200 glargine - the CONCLUDE trial - P GaedeComparing semagutide vs canaglflozin - the SUSTAIN 8 trial - M FisherCV outcomes with linagltin vs glimepiride - the CAROLINA trial - M FisherDiscussion

10.45-12.15pm

Futuristic view of cardio-diabetes management IntroductionIncretin-based therapies: where will we be 50 years from now? - M Nauck What Does the Future Hold? - E FerranniniDiscussion

12.15-1.30pm

1.00pm Lunch

Prioritizing injectable therapies in diabetes

GLP1RAs: From anti-diabetic to cardiometabolic drug - M NauckCV safety with basal insulins -Uday PhadkeTackling Post Prandial Peaks and Outcomes - S.KaleAchieving Glycemic Goals :Indian reality- Prasoon DebDiscussion

9.15-10.45am

20min


15min

15min

15min

15min

15min

18min +6min

18min +6min10min

DAY III 10TH NOV,SUNDAY HALL I

Guest Lectures

The need for new trials of old drugs: ACEi/ARB and beta blockers in post MI patients - B GershHow to assess heart failure with preserved ejection fraction? - J Bax(Dr Reddy's)The very high risk CVD-role of PCSK9 inhibitors - JJ DalalDiscussion

9.15-10.45am

25+5min

25+5min

25+5min

Clinical Scenarios

Calcium score & CT coronary angio in high risk patients - MS HiremathWhat Physicians should know about FFR? - R MathewHeart rate reduction - S SatheType A Avortic dissection : a tough call - S BanerjeeDiscussion

12.15-1.30pm

1.00pm Lunch

Stroke for Physicians

Acute stroke : Time is brain - S HastakControl of BP in stoke - S BansalAlgorithm Based Management with Dabigatran - G KoshyDiscussion

10.45-12.15pm


15min

12+6min


DAY III 10TH NOV,SUNDAY HALL II

Session I IntroductionCourse Directors- M Fisher, P GaedeGlycaemic management to reduce micro and macro-vascular disease - M FisherDiscussionInsulin management for type 1 and type 2 diabetes - P GaedeDiscussionClosing Remarks

11.00am-12.15pm

FEAC ConvocationWelcome lectureCeremonyGroup Photograph

8.15-9.15am

EACD ConvocationWelcome lectureCeremonyGroup Photograph

9.15-10.45am

EASD Half-day Postgraduate Education Course

30min

30min

Workshop IGlycaemic management to reduce micro and macro-vascular disease

12.15-1.00pm

1.00-1.45pm Lunch

Workshop IIInsulin management for type 1 and type 2 diabetes

1.45-2.30pm

Session IIIntroductionMulti-risk factor interventions - Steno 2 and beyond - P GaedeDiscussionFuture prospects for glycaemia, lipids and blood pressure management - M FisherDiscussionClosing Remarks

2.30-3.45pm

3.45-4.00pm Certification & photograph

30min

30min

DAY III 10TH NOV,SUNDAY HALL III

1 final scientific program1 (1) · new nice guidelines : a realistic compromise? - b williams...

Documents